baber/WOPTO huggingface dataset:
Patent PT-944610-E (PT)
Inventor: PARSONS RODNEY LAWRENCE JR
IPC: C07D265/18
Filed: 1997-12-15
Abstract: Process for asymmetric synthesis of benzoxazinone derivatives of formula (VI), comprises: (a) reacting (I) with (VII) or (VIII) in the presence of an acid catalyst to give (II) which is reacted with a mixture of (IX), alkyl lithium and cyclopropylacetylene to give (III); (b) (III) is oxidised to (IV) and this is reacted with a cleaving agent and a trapping agent to give (V); and (c) (V) is treated with a cyclising agent to give (VI). X = Cl or F; A = CF3, C2F5 or C3F7; R1 = H, 1-6C alkyl or 1-6C alkylcarbonyl; R2 = H; R3 = H, Me, Et or phenyl substituted by up to 3 of R12; R4, R5, R4a, R5a, R6, R8, R9 = H, 1-6C alkyl, 1-6C alkoxy or 1-6C alkylthio; R12 = H, 1-6C alkyl, 1-6C alkoxy or 1-6C alkylthio; Y = (CH2)n or O; n = 0 to 3; P = amine protecting group of formula (a) or (b); P" = group of formulae (c) or (d); R10, R11 = 1-4C alkyl; or NR10R11 = pyrrolidinyl, piperidinyl or morpholinyl.
Patent CA-2699556-F (CA)
Title: Mobile elevating work platform
Inventor: EARL JOSEPH L J
IPC: B66F7/02
Filed: 2010-04-15
Granted: 2011-05-11
Abstract: There is provided a mobile height-adjustable platform that includes a chassis with ground engaging wheels. A mast is pivotally connected to the chassis and is movable between a transport position where the mast is parallel to and disposed over the chassis, and an operative position where the mast is perpendicular to the chassis and extends upwards. A conveyor moves along the mast and a work platform is pivotally connected to the conveyer. The work platform is movable between a transport position where the platform is parallel to the mast and an operating position where the platform is perpendicular to the mast.
Patent SG-25190-G (SG)
Title: Multi-function natural gamma ray logging
IPC: G01V5/06
Filed: 1990-03-30
Abstract: A multi-function compensated spectral natural gamma ray logging method provides for determining formation and borehole characteristics directly from naturally occurring formation radiation. The method, which measures formation lithology in open holes and mean casing thickness in cased wells, incorporates active compensation for differences in borehole conditions when calculating relative elemental formation abundancies or concentrations of potassium (K), uranium (U) and thorium (T).
Patent SG-58786-G (SG)
Title: Method of producing cover fabrics for v belts and cover fabrics so produced
IPC: B29D29/00
Filed: 1986-07-03
Abstract: A fabric is bias cut into a continuous strip of fabric. The individual fibers in the continuous strip (12) are impregnated with an elastomeric polymeric material effective to increase the flex and wear-life of the fabric when used as a cover fabric for V belts. This impregnation is accomplished by immetsing the strip (12) in a fluid mix (13) having a viscosity of about 2000 cps or less, the mix including a fluid carrier, an elastomeric polymer (e.g. a polychloroprene compound) and a dark pigment. A coating (16) of an elastomeric polymer (e.g. another polychloroprene compound) is applied to the strip, the strip is streched in its width direction to increase the angular relation of the threads of the fabric relative to its longitudinal axis, and the thus coated strip is dried (20). The continuous strip is ultimately slit (24) longitudinally of itself into a plurality of tapes, and the tapes (26) are used to cover a V belt.
Patent IE-800056-L (IE)
Title: Mesh band conveyor
IPC: B65G15/46
Filed: 1980-01-11
Abstract: A wire mesh band or belt for a conveyor having downwardly extending protuberances for engaging peripheral grooves in rollers of a conveyor system to maintain the band in proper transverse position. The protuberances are formed on guide wires woven into the band at lateral and longitudinal intervals in the weft direction. The guide wires have at least one flattened surface so that they cannot rotate about their longitudinal axis. In a second embodiment, instead of continuous guide wires, a plurality of guide wire sections may be arranged at intervals transversely across the band.
[US4318469A]
Patent IE-45085-L (IE)
Title: Protected (hydroxy-5-oxocyclopent-1-enyl) heptanes and¹hept-5z-enes
IPC: A61K31/12
Filed: 1977-01-17
Abstract: Novel bicycloalkyl analogues or derivatives of prostaglandin A, E and F are useful modifiers of smooth muscle activity. The compounds have valuable pharmacological properties as platelet antiaggregating agents and gastric antisecretory agents. The compounds are also valuable pharmacological agents for increasing femoral blood flow and decreasing blood pressure and heart rate.
[US4074063A]
Patent IE-32865-L (IE)
Title: Friction false twisting
IPC: D02G1/02
Filed: 1969-01-23
Abstract: 1,212,393. Friction false twisting. IMPERIAL CHEMICAL INDUSTRIES Ltd. 23 Jan., 1969 [30 Jan., 1968], No. 4777/68. Headings DID, D1F and D1W. In a process for friction false twisting a twist barrier comprising a stationary pin 13 is so positioned with respect to the outlet end of a friction false twist tube 5 and with respect to guide means 17 around or through which the yarn is withdrawn from the twist tube that the yarn may be partially wrapped around the pin 13 with an arc of contact between 45 and 180, contact with the pin 13 being made immediately after the yarn has left contact with the outlet end of the twist tube 5. The pin 13 may have a bright or matt chrome surface or a ceramic surface. In a preferred embodiment the pin 13 has a diameter of 1/16 inch and is at a distance 1/8 inch from the peripery of the outlet end of the twist tube. The arc of contact between the yarn and the pin is prefemaibly between 60 and 100. The yarn produced has virtually no residual twist left after a de-twisting step and therefore fabric produced from the yarn has no undesirable 'flashes'.
[GB1212393A]
Patent IE-37140-L (IE)
Title: 1, 3-diamino-2-propanols
IPC: C07C233/68
Filed: 1973-01-23
Abstract: 1399261 Cardiovascular medicines SCIENCE UNION ET CIE SOC FRANCAISE DE RECHERCHE MEDICALE 23 Jan 1973 [24 Jan 1972] 3237/72 Heading A5B [Also in Division C2] Pharmaceutical compositions having cardiovascular properties for oral, parenteral, sublingual or rectal administration comprise a compound of formula I wherein Y, Y' and Y" are independently H, halogen, optionally substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy or CF 3 radical; R, which may be in the 5-, 10- or 11-position is a radical of general formula II wherein R, is H or an optionally substituted C 1 -C 6 alkyl, R 2 is H, optionally substituted C 1 -C 6 alkyl, C 2-10 alkenyl or benzyl radical, R 3 is optionally substituted C 1 -C 6 alkyl, C 2 -C 10 alkenyl, C 2 -C alkynyl or aryl-C 1 -C 6 alkyl radical or R 2 -N-R 3 represents a 5-7 membered heterocyclic ring which optionally contains a further hetero atom selected from O, N-S, the dotted line indicating an optional double bond, or acid addition salt thereof together with a pharmaceutically acceptable carrier and optionally another active ingredient having similar or synergistic properties such as a #-receptor blocker (e.g. propanolol or practolol), a coronarydilator (e.g. dipyridamol or a nitrated polyol), an anticoagulant agent (e.g. ethyl bis coumacetate or Acenocoamarol) or a compound which has a pharmacological action similar to that of digitalin.
[GB1399261A]
Patent IE-900220-L (IE)
Title: Method for die release during catheter tipping
IPC: B29C57/00
Filed: 1990-01-19
Abstract: A method for catheter tipping includes applying to a catheter blank a layer of a noncuring aminoalkyl terminated polysiloxane lubricant, mounting the lubricated blank on a mandrel and advancing the mandrel-catheter assembly into a heated die so that the die causes the heated tip of the blank to assume the shape of the die. The catheter may then be cut beyond the shaped tip and easily removed from both the die and the mandrel.
Patent IE-34313-L (IE)
Title: 2-hydroxy-5-aminobenzamides
IPC: A61K/
Filed: 1970-06-16
Abstract: 1,272,477. 2 - Hydroxy - 5 - aminobenzamide derivatives. SOC. D'ETUDES, DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES ET MEDICALES. 22 June, 1970 [20 June, 1969], No. 31267/69. Heading C2C. The invention comprises novel benzamides of the formula where R is allyl or propargyl; R 1 is H or C 1-5 alkyl; R 2 is C 1-5 alkyl, C 2-5 alkenyl or C 3-6 cycloalkyl, or R 1 and R 2 together with the N atom to which they are attached form a pyrrolidino, piperidino or morpholino radical; R 5 and R 6 are each H or C 1-5 alkyl and, when R 5 and R 6 are both alkyl they are the same; and at least one of R 3 and R 4 is H, the other being H, Cl or CH 3 ; and pharmaceutically acceptable acid addition salts. The compounds of the above formula in which both R 5 and R 6 are H are prepared by hydrolysing the corresponding 5- acetamide derivatives; compounds in which R 5 is H and R 6 is C 1-5 alkyl are obtained by alkylating the corresponding 5-acetamido derivatives and hydrolysing the resulting alkylated products; and compounds in which R 5 and R 6 are the same C 1-5 alkyl are produced by alkylating the corresponding compounds of the above formula in which R 5 and R 6 are H. N - (n - Butyl) - 2 - allyloxy - 5 - (N - methylacetamido) benzamide is obtained by treating N- (n - butyl) - 2 - allyloxy - 5 - acetamidobenzamide with sodium hydride and methyl iodide. Pharmaceutical compositions, suitable for oral administration and having muscle relaxing and anti-inflammatory activities, contain the above novel compounds or therapeutically acceptable acid addition salts thereof and pharmaceutical carriers.
[GB1272477A]
Patent IE-860900-L (IE)
Title: Improving alumina precipitation using polymers in the bayer¹process of bauxite beneficiation
IPC: C01F7/145
Filed: 1986-04-07
Abstract: The negative effects of sodium oxylate on the crystallization of aluminum trihydrate from Bayer process liquors may be eliminated or curtailed by adding an effective amount of a polyacrylic acid with a molecular weight about 1,000,000 and containing at least 50 mole percent acrylic acid monomer to pregnant Bayer process liquors.
[US4608237A]
Patent IE-790954-L (IE)
Title: Pharmaceutical formulations containing prostaglandin¹compounds
IPC: A61K47/18
Filed: 1979-08-08
Abstract: Stabilised pharmaceutical formulations of prostacyclin, 15- methyl-prostacyclin or 16,16- dimethylprostacyclin are prepared by addition of a buffer comprising an amino acid (preferably glycine) as the principal buffering agent.
[GB2021581A]
Patent FI-820992-L (FI)
Inventor: KELLOGG MICHAEL STEPHEN
IPC: C07D499/00
Filed: 1982-03-22
Abstract: Novel bis-Esters of 1,1-alkanediols with 6-beta(hydroxymethyl)penicillanic acid 1,1-dioxide and 6-betaacylaminopenicillanic acids are useful as antibacterial agents. Novel intermediates useful for the preparation of these compounds include: haloalkyl, alkylsulfonyloxyalkyl and arylsulfonyloxyalkyl esters of 6-beta-(hydroxymethyl)penicillanic acid and its 1-oxide and 1,1-dioxide; 6-beta-aminopenicillanoyloxyalkyl and 6-beta-(N-protected-D-2-amino-2-phenylacetamido and 2-[4-hydroxyphenyl]acetamido) penicillanoyloxyalkyl esters of 6-beta-(hydroxymethyl)penicillanic acid 1,1-dioxide; and haloalkyl, alkylsulfonyloxyalkyl and arylsulfonyloxyalkyl esters of the 6-bromo-6-(hydroxymethyl)penicillanic acids.
Patent FI-831445-L (FI)
Inventor: BARTHELEMY PIERRE
IPC: A23C19/032
Filed: 1983-04-27
Abstract: A process for improving the cheese capacity of milk used in the preparation of soft paste cheeses intended to be ripened comprising adding during the course of the preparation of the soft paste cheese an enzyme extracted from a culture of Micrococcus caseolyticus to the milk; and the cheese prepared thereby.
Patent FI-844467-L (FI)
Inventor: STRIDSBERG LENNART
IPC: G02B26/10
Filed: 1984-11-14
Abstract: The apparatus includes control means (209) sending command signals to the positioning apparatus (204). It is intended during a working state to locate an object (203) in relation to an operating area (509), the situation of the apparatus being sensed (308, 205) and converted to an actual value signal which is sent to the control means. The positioning apparatus has a working state which is interrupted at given intervals by a calibrating state, during which the positioning apparatus is accurately put in register with at least one detector (208), situated within the operating area in a given position. The output signals from the detectors are allowed to activate the control means, whereafter the actual value signal is determined and the positioning apparatus calibrated in response to the determined actual value signal.
Patent IE-35524-L (IE)
Title: Preventing relative movement between rear facing doors of¹vehicles
IPC: E05F7/00
Filed: 1971-08-17
Abstract: 1308927 Positioning of doors HERBERT LOMAS Ltd 12 Aug 1971 [26 Nov 1970] 56540/70 Heading E2X A device for preventing relative movement between two doors or one door and a door post of a vehicle comprises a bracket A mounted on a doorpost or as shown on a door B and a bracket D which has a roller d<SP>2</SP> mounted thereon, secured on a first door B<SP>1</SP>, said roller engaging the channel part a (flared as shown) when the doors close. The roller may have chamfered edges.
Patent IE-781120-L (IE)
Title: High fructose syrup
IPC: C07H3/02
Filed: 1978-06-02
Abstract: This invention relates generally to (1) processes for the production and isolation of a novel fructosyl transferase enzyme from the fermentation broth of Pulluaria pullulans, (2) enzymatic transfructosylation of sucrose to produce a novel fructose-polymer containing substrate, and (3) production of fructose syrups containing greater than 55% fructose from said novel substrate.
[GB2000144A]
Patent IE-43713-L (IE)
Title: 3-pyridylmethyl thiocarbamate derivatives
IPC: C07D213/30
Filed: 1976-06-10
Abstract: Novel 3-pyridylmethyl N-(4-substituted-phenyl)thiocarbamates are disclosed. These compounds are useful as single-dose rodenticides, which have high bait acceptance.
[US4156780A]
Patent IE-791272-L (IE)
Title: Cis-1,2-epoxypropylphosphonic acid.
IPC: C07F9/38
Filed: 1979-08-08
Abstract: Salts of (-)-cis-1,2- epoxypropylphosphonic acid with non toxic bases, useful as antibiotics, are prepared from racemic cis-1,2- epoxypropylphosphonic acid using L(+)-threo-1-(p- methylmercaptophenyl)-2-amino-1,3- propanediol as resolving agent.
[GB2024826A]
Patent IE-36724-L (IE)
Title: Imidazole derivatives
IPC: C07D235/04
Filed: 1972-09-25
Abstract: The disclosure relates to bis(imidazolium quaternary salts), a process for their manufacture, compositions containing them, and a method of preventing the growth of, or killing, bacteria by applying one of the novel imidazolium salts to a bacterially-infected environment.
[US3853907A]
Patent IE-831448-L (IE)
Title: Extended action controlled release compositions.
IPC: A61K31/52
Filed: 1983-06-20
Abstract: The action of controlled release medications is extended by incorporation into the controlled release matrix for a medication a mixture of the salt form of the medication with the free base form of the medication in a proportion of a 75-25% by weight of the salt form to 25-75% by weight of the free base form, the weight amounts being calculated with respect to the active base.
[US4443428A]
Patent IE-39599-L (IE)
Title: Graft polymers and compositions of high impact strength
IPC: C08F285/00
Filed: 1974-07-09
Abstract: Graft polymers based upon butadiene, alkyl acrylate, methyl methacrylate and styrene, for the improvement of the impact strength of homo- or co-polymers of vinyl chloride. Use is made of a backbone polymer formed of a butadiene-alkyl acrylate copolymer which is agglomerated and grafted with methyl methacrylate, styrene and possibly a cross-linking monomer. The composition, mixtures of homo- or co-polymers of vinyl chloride and graft polymers are usable for the manufacture of plates, bottles, wrapping sheets and bottles for packaging liquids.
[US4078018A]
Patent IE-891910-L (IE)
Title: 3-deoxy mycaminosyl tylonolide derivatives
IPC: A61K31/7048
Filed: 1989-06-13
Abstract: 3-Deoxy mycaminosyl tylonolide derivatives represented by the following general formula and salts thereof: <CHEM> wherein X represents an oxygen atom or =N-OR<4> (wherein R<4> represents hydrogen or lower alkyl); R<1> represents a hydrogen atom, an acyl group or an alkylsilyl group; R<2> represents a hydrogen atom or an acyl group; and R<3> represents a hydrogen atom or a hydroxyl group. The compounds of formula (I) have excellent antibacterial activity.
Patent IE-852091-L (IE)
Title: Diffusion barrier layer for integrated circuit devices
IPC: H01L29/43
Filed: 1985-08-26
Abstract: Titanium carbonitride has been discovered to be an effective diffusion barrier material for use in metallization structure for MOS integrated-circuit devices. A layer of the material (24) deposited under aluminum (22) prevents deleterious aluminum-silicon or aluminum-silicide interactions.
[WO8601640A1]
Patent IE-802212-L (IE)
Title: Multilayer capacitors
IPC: H01G4/232
Filed: 1980-10-24
Abstract: Air fireable nickel boride-based end termination compositions for multilayer capacitors are provided. The nickel boride compounds utilized are either (Ni3B)a(Ni3Si)b or Ni3B1-xPx and the compositions also contain a glass whose component oxides have a redox potential of less than -0.5 volt. These compositions, upon firing, afford conductors such as end terminations in multilayer capacitors having excellent solderability and solder leach resistance, adhesion to dielectric substrates and electrical properties substantially equivalent to standard silver/palladium conductors.
[US4271236A]
Patent IE-852272-L (IE)
Title: Toothpaste compositions
IPC: A61K8/81
Filed: 1985-09-13
Abstract: Toothpastes are disclosed which contain water, humectant, a dentifrice abrasive, a carboxyvinyl polymer and carrageenan.
Patent IE-842908-L (IE)
Title: Oxo-analogs of mevinalin
IPC: C07C69/76
Filed: 1984-11-13
Abstract: Mevinolin-like compounds of the structural formula: <CHEM>  are disclosed wherein:  R<1> is, e.g., hydrogen or C1-4alkyl;  E is -CH2CH2, -CH=CH-, or -(CH2)3-; and  Z is <CHEM>  wherein X is -O-or-NR<9> wherein R<9> is hydrogen or C1-3alkyl;  R<7> is C2-8alkyl; and  R<8> is hydrogen or -CH3; <CHEM> wherein R<1><0>, R<1><1> and R<1><2> are independently, e.g., hydrogen, halogen or C1-4alkyl;   <CHEM>  wherein n is 0-2 and R<1><4> is halo or C1-4alkyl; or <CHEM> wherein the dotted lines represent possible double bonds there being 0, 1 or 2 double bonds;  m represents 1, 2 or 3; and  R<1><5> is methyl, hydroxy, C1-4alkoxy, oxo, or halo. Those compounds are potent HMG-CoA reductase inhibitors possessing one less asymmetric centre.
Patent IE-893516-L (IE)
Title: Immunoassay on a preblocked solid surface
IPC: G01N33/58
Filed: 1989-11-01
Abstract: A method for immunoassay of a viral antigen is performed on a membrane precoated with an inert protein. Nonimmunological capture of antigen takes place by absorption onto the coated membrane. Captured antigen binds to a tracer which includes a label conjugated to a specific antibody, the inert protein concomitantly inhibiting nonspecific binding of tracer. The label may be an enzyme which converts a substrate to a detectable product or converts a blocked inhibitor to an inhibitor whereby a second enzyme is inhibited from converting a substrate to a product. The invention includes a kit of materials for performing an assay in accordance with the method of the invention.
[EP0369361A2]
Patent NO-801323-L (NO)
Inventor: LUDWIG BERND
IPC: H01H19/64
Filed: 1980-05-06
Abstract: The electric switching apparatus assembled of a plurality of consecutively arranged modular units, includes snap action arresting means integrally formed on opposite side walls of each unit. The arresting means includes frame-shaped resilient arresting pieces leveled with the upper surface of the assigned side wall and being at one edge thereof integrally connected thereto and cooperating with matching arresting points on the adjoining unit.
Patent NO-832743-L (NO)
Inventor: BUSK ROBERT SCHOLLEY
IPC: B22D27/11
Filed: 1983-07-28
Abstract: A process for producing a liquid-solid composition comprising heating a liquefiable material sufficiently to form a liquid phase with solid dendritic particles therein without completely liquefying the material and subjecting said liquid-solid material to a shearing action sufficient to break at least a portion of the dendritic structures. The process includes injection molding, forging or die casting the material produced by the process.
Patent NO-832782-L (NO)
Inventor: ZAHRADNIK ROBERT THOMAS
IPC: A61K6/02
Filed: 1983-08-01
Abstract: A neutral topical sodium fluoride gel is disclosed which comprises a thickened aqueous solution of sodium fluoride buffered to maintain a pH of from about 5 to 9.
Patent NO-841023-L (NO)
Inventor: BUNDESEN PETER GREGORY
IPC: G01N33/68
Filed: 1984-03-16
Abstract: The invention relates to a method of preparation of monoclonal antibody derived from a crosslinked fibrin derivative including the steps of:(i) obtaining a crosslinked fibrin derivative or extract containing same; and(ii) forming antibody to said derivative or extract by cloning antibody producing cells from an animal having been administered thereto said derivative or extract.There is also provided a screening assay for use in the abovementioned method which includes the steps of:(A) coating a surface with antigen selected from(i) crosslinked fibrin derivative;(ii) extract containing said derivative; or(iii) fibrinogen degradation product.(B) contacting said antigen with monoclonal antibody derived from crosslinked fibrin derivative; and(C) subjecting the complex formed in step (A) to a signal amplification step.There is also disclosed an assay procedure for detection of the presence of a crosslinked fibrin derivative in an animal body fluid including the steps of:(i) contacting monoclonal antibody prepared from a crosslinked fibrin derivative with a fluid sample suspected of containing an antigen derived from a crosslinked fibrin derivative or comprising a crosslinked fibrin derivative perse; and(ii) subjecting the complex formed in step (1) to a signal amplification step.
Patent NO-852591-L (NO)
Inventor: SAMSON JOHN NORMAN REID
IPC: C08F4/14
Filed: 1985-06-27
Abstract: This invention relates to a process for producing polyisobutene which has at least 70% of its unsaturation in the terminal position. The process uses a complex of boron trifluoride and alcohol as catalyst and a contact time of at least 8 minutes. The feature of the process is its ability to use longer contact times than used hitherto thereby facilitating its commercial operation and improving the control of such an operation. The high terminal unsaturation improves the reactivity of the polymer.
Patent NO-870780-L (NO)
Inventor: FOSSEL ERIC T
IPC: G01N33/49
Filed: 1987-02-25
Abstract: A technique is disclosed for the detection of cancer using nuclear magnetic resonsance (NMR). Specifically, NMR parameters for protons of lipid methyl and/or methylene groups are determined and compared against a corresponding value for healthy patients. In the preferred embodiments, an NMR spectrometer is employed in conjunction with a Fourier transformer to provide a spectrum for non-water components of blood, blood serum or blood plasma and the width of the methyl and/or methylene groups is measured at half-height as a determination of spin-spin relaxation time (T2) which is the parameter used for purposes of comparison with healthy controls. Suppression of the water proton signal is employed where necessary in order to obtain a suitable spectrum for the non-water component protons.
Patent NO-884931-L (NO)
Title: Saapepute.
Inventor: CHOWN PETER ARTHUR CHARLES
IPC: A47L17/08
Filed: 1988-11-04
Abstract: Såpepute (2) omfattende såpe, svampaateriale (6) og stålull (4) tilveiebragt rundt svampmaterialet (6).
Patent NO-892630-L (NO)
Inventor: NAMEN ANTHONY E
IPC: C07K14/00
Filed: 1989-06-23
Abstract: Mammalian Interleukin-7 proteins (IL-7s), DNAS and expression vectors encoding mammalian IL-7s, and processes for producing mammalian IL-7s as products of cell culture, including recombinant systems, are disclosed.